Explore Teva in the UK
Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the world
Teva is a big player on the world stage - that brings considerable benefits to patients in the UK
You might be surprised to learn that we've been supplying medicines for over 80 years in the UK. We were established in Yorkshire back in the 1930s – which means we’ve been around longer than the NHS!
Enabling access to high quality medicines and treatment options
At Teva we believe that everyone should have access to high quality medicine that helps manage disease, fights infection, or simply improves overall health
We develop, produce and market affordable generic medicines, as well as innovative and specialty pharmaceuticals and biologics, and over-the-counter consumer healthcare products. That’s along with supplying active pharmaceutical ingredients to nearly 1,000 customers in over 100 countries.
Our diverse family of over 37,000 employees is the beating heart of our company, working together to find innovative and creative solutions to the healthcare challenges of today and tomorrow.
As the global leader in generic medicines, nearly 200 million patients across six continents take one of our products every day. 01
Concentrating our efforts on core therapeutic areas
We focus on developing, personalising and improving treatment of disorders of the central nervous system, migraine, respiratory conditions, oncology and pain management.
Our medicines improve the lives of patients in so many ways - that could be by fighting infections and controlling cholesterol, or it could be through offering flexible treatment options for migraine, relieving the symptoms of asthma, or providing lifesaving injectable medicines and pain relief for cancer sufferers.
We’re also the company behind well-known brands in the consumer health and baby care sector, such as Sudocrem® and Infacol®.
Migraine
Chronic and episodic migraine
Respiratory
Asthma and chronic lung diseases
Oncology & Pain
Pain management and cancer therapies
We play an important role in delivering value to healthcare systems and economies around the world
The scale of production and accessible price of our products help to limit rising healthcare costs and improve patient health outcomes.
We also invest hundreds of millions of pounds every year to enable our scientists to develop specialty and biopharmaceutical treatments that aim to improve patients’ health and increase access to medicines.
Delivering value to the NHS
Like all health systems globally, the NHS is under intense financial pressure driven by growing patient demand from a population that is aging (who are often managing multiple chronic conditions) and by rising costs.
We're working hard to help the NHS do more with less, by delivering value through our generic medicines. They are typically sold at a substantially lower price compared to their branded medicine counterparts, as the development process is generally less costly.
Generic medicines bring significant savings to the NHS medicines bill – estimates are that generic medicines save the NHS around £13 billion every year, in England and Wales, compared to the cost if their branded equivalents had been dispensed.02 This frees up valuable NHS resources to be directed to where patients need them most.
As one of the leading generic medicines suppliers in the UK, Teva was responsible for £2.4 billion of these savings in 2021 - that’s the equivalent of more than 96,000 new nurses or over 83,000 junior doctors.03
Proud to be positively impacting the UK’s Economy
Teva is a major employer in the UK with over a thousand highly skilled colleagues working in our research, manufacturing and commercial operations
As an employer and a manufacturer, Teva creates jobs and contributes to economic output. Beyond direct expenditures, Teva's spending initiates a series of income creation, spending and re-spending that support other jobs and contribute to additional Gross Domestic Product (GDP) and overall economic output.
Teva’s economic impact in 2020 included supporting nearly 41,000 full-time jobs, contributing £10.1 billion to economic output and generating £2 billion in labour income, a measure of aggregate worker wages. 06
Investing in the UK
We have sites across the UK with extensive operations that span all aspects of bringing medicines to market. They are, all working together to provide high-quality medicines to millions of patients - not just in the UK, but worldwide.
Research and Manufacturing
Runcorn, Cheshire is home to our manufacturing facility for sterile liquid products, mainly used in the treatment of respiratory conditions, as well as multiple sclerosis and migraine, which are distributed to countries around the world. It’s also the base for two research and development centres developing sterile drug products and sterile device technology.
Our Larne site in Northern Ireland is a research and development facility focusing on branded and generic developments in medical implants and devices.
Commercial activities
Our UK commercial headquarters and hi-tech logistics centre are based in Castleford, in the heart of the West Yorkshire.
Our site in Harlow is home to many of our specialist teams, including Sales and Marketing, Medical, Regulatory Affairs and Legal. It’s a Centre of Excellence for Regulatory Affairs within Teva, with teams covering both European and global licensing for medicines and over-the-counter (OTC) products.
Our field-based medical and commercial teams working with customers right across the UK.
Leveraging our global size and strength
Teva is a big player on the world stage - that brings considerable benefits to patients in the UK
We are continually expanding our range of medicines, devices and services to better meet the needs of UK patients and to offer increased choice to healthcare professionals.
We produce approximately 76 billion tablets and capsules a year through our 53 manufacturing facilities in more than 30 countries. 07
We have a strong pipeline of innovative medicines at various developmental stages and we are actively investigating novel uses for existing treatments.
Improving the lives of patients
Right now all across the country…
-
A doctor is writing a prescription for a Teva medicine, to improve their patient’s health outcome
-
A pharmacist is reaching for a Teva product, secure in the knowledge that Teva medicines meet the highest standards for quality and safety
-
A parent is trusting a Teva medicine to help a sick child get well
And that means all across the UK, people you probably know are living a healthier life because of our medicines.
References
-
Back to contents.
Internal analyses conducted by Teva's Global Insights, Access & Technologies Department estimating number of Teva consumers.
-
Back to contents.
British Generics Manufacturers Association https://www.britishgenerics.co.uk/about-generics.html - Accessed August 2022
-
Back to contents.
Teva UK - Data on file
-
Back to contents.
Teva UK - Data on file
-
Back to contents.
Teva UK - Data on file
-
Back to contents.
Teva Economic Impact Report - Matrix Global Advisors estimate of Teva’s Macroeconomic Impact in the UK in 2020
-
Back to contents.
Teva Global Operations - Internal Data Source
Fast track your career
We can offer you the chance to make a real difference in people's lives and add value to your career